Topic

Chemotherapy


JNM: PET/CT, SPECT/CT integral in cancer treatment planning

Top Stories | Wednesday, September 01 2010

A series of studies published in the September issue of the Journal of Nuclear Medicine show that molecular imaging plays a critical role in the evaluation and treatment planning for a spectrum of cancers, including thyroid cancer, neuroendocrine tumors, Hodgkin lymphoma and non-small cell lung cancer.
 

Study: Chemoradiotherapy improves survival in women with cervical cancer

Clinical Studies | Sunday, August 22 2010
The addition of chemotherapy (cisplatin) to radiotherapy improves survival of women with locally advanced cervical cancer compared with radiotherapy alone, without an apparent rise in late treatment complications, according to a study published in the September issue of Clinical Oncology.
 

NCI grants Solixia $161K for ovarian cancer research

Industry News | Monday, August 16 2010
Radiopharmaceutical company Solixia has been awarded a $161,000 Phase I small business innovation research grant from the National Cancer Institute (NCI) for its project that will develop and test a pharmaceutical agent for the treatment for ovarian cancer.
 

AJR: Preradiotherapy FDG PET modifies treatment in NSCLC

Clinical Studies | Sunday, August 15 2010
Preradiotherapy FDG PET for non-small cell lung cancer (NSCLC) patients referred for 3D conformal radiotherapy may lead to significant modification of treatment strategy and radiotherapy planning, according to a prospective multicenter study published in the American Journal of Roentgenology.
 

Study: Breast cancer deaths drop in Europe, partly due to mammo screenings

Top Stories | Wednesday, August 11 2010
Changes in breast cancer mortality after 1988 varied widely among European countries, and the U.K. is among the countries with the largest reductions, found a study published Aug. 11 in the British Medical Journal.
 

ASTRO: Hypofractionated-whole breast irradiation suitable for early-stage cancers

Industry News | Thursday, August 05 2010
The American Society for Radiation Oncology (ASTRO) has released evidence-based guidelines supporting the use of hypofractionated (HF) whole breast irradiation (WBI) for certain patients with early-stage breast cancer, based on the findings of a study published in the August edition of the International Journal of Radiation, Oncology, Biology and Physics.
 

Siemens, RSNA issue 2010 rad research grant winners

Industry News | Monday, August 02 2010
The Radiological Society of North America (RSNA) Research and Education Foundation and Siemens Healthcare have announced the two winners of the 2010 Siemens Healthcare/RSNA radiology research grants.
 

PNAS: Biophotonic imaging reveals real-time cell death changes

Clinical Studies | Wednesday, July 28 2010
Scientists have developed a biophotonic imaging approach for studying the molecular organization and its transformation in cellular processes, with the specific example of apoptosis, according to a study published July 20 in Proceedings of National Academy of Sciences.
 

AAPM: Cancer survivor says ‘thanks’ to medical physicists, oncologists

Conference News | Tuesday, July 20 2010
Written by Chris Kaiser
PHILADELPHIA—Six years ago, Jim Donnelly was told the cancer on his tongue and larynx needed to be surgically removed. Not accepting that opinion, Donnelly, a professor of business at the University of Kentucky, Lexington, decided to go to the Mayo Clinic in Rochester, Minn. As was evident by the standing ovation following his address at the annual meeting of the American Association of Physicists in Medicine (AAPM), Donnelly has not lost his ability to speak, nor his sense of humor.
 

Study: Chemo+radiation therapy reduces cancer-specific deaths

Clinical Studies | Thursday, July 15 2010
Adding concurrent-adjuvant chemotherapy to radiation therapy can reduce cancer-specific deaths, but increases acute toxicity for nasopharyngeal carcinoma patients, according to a study published online July 15 in the Journal of the National Cancer Institute.
 

Study: SAVI increases accelerated partial-breast irradiation eligibility

Clinical Studies | Wednesday, July 14 2010
The multichannel single-entry brachytherapy device, the Strut-Adjusted Volume Implant, can safely allow an increase in eligibility for accelerated partial-breast irradiation compared to balloon brachytherapy or 3D conformal radiation, according to a study published June 18 in the International Journal of Radiation Oncology, Biology and Physics.
 

AngioDynamics expands power-injectable port line

New Products | Monday, July 12 2010
AngioDynamics has expanded its line of power-injectable ports, Smart Port CT, to include low-profile and mini models for repeat treatments and use with CT.
 

Study: Endoscopic ultrasound proves valuable for pancreatic cancer patients

Clinical Studies | Monday, July 12 2010
Endoscopic ultrasound evaluation in patients with locoregional pancreatic cancer can be associated with improved outcomes and may aid earlier detection, according to a study published in the July issue of Gastrointestinal Endoscopy.
 

GE collaborates on investigational molecular breast imaging system

Partnerships & Alliances | Friday, June 18 2010
GE Healthcare is collaborating in two clinical trials with the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel, and the Hamilton Health Sciences Hospital in Hamilton, Ontario, on the use of a new technology that may assist in assessment and early detection of breast cancer in women who are at high risk for the disease.
 

ASE: Biomarkers may predict chemo-related cardiotoxicity

Conference News | Tuesday, June 15 2010
According to research presented during the 21st annual scientific sessions of the American Society of Echocardiography (ASE) in San Diego this week, cardiac troponin plasma concentrations and longitudinal strain can predict the development of cardiotoxicity in patients treated with anthracyclines and trastuzumab chemotherapies.
 

ASCO: Oropharyngeal cancer survival can be predicted by HPV

Conference News | Monday, June 07 2010
Oropharyngeal squamous cell carcinoma caused by human papillomavirus (HPV) is a strong and independent prognostic factor for survival among patients with oropharyngeal cancer, according to research from the Radiation Therapy Oncology Group (RTOG) published on June 7 in the New England Journal of Medicine and presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
 

ASCO: Preoperative therapy responses in pancreatic cancer may predict survival

Conference News | Friday, June 04 2010
Major pathologic response to preoperative chemotherapy and radiation occurs in a minority of patients with pancreatic adenocarcinoma and is independently associated with prolonged survival, according to a study presented at the 46th annual meeting of the American Society of Clinical Oncology (ASCO) on June 6 in Chicago.
 

IntelliDose chemo management to be integrated into Allscripts EHRs

Partnerships & Alliances | Friday, May 28 2010
Allscripts will integrate IntrinsiQ's IntelliDose chemotherapy management tool into its EHR product suite as a new offering for physician practices.
 

ISCT Feature: Annual Workstation Face-Off was ‘impressive’

Web Exclusives | Saturday, May 22 2010
In front of a full conference room at the International Symposium on Multi-Detector Row CT last week, Carestream Health, GE Healthcare, Philips, Siemens, TeraRecon, Vital Images and Ziosoft competed in the eighth annual Workstation Face-Off in San Francisco, yielding “impressive and surprising results,” the event's moderator Geoffrey D. Rubin, MD, said in an interview.
 

Study: Exercise may combat adverse chemotherapy side effects

Conference News | Friday, May 21 2010
Preliminary data indicate that performing mild exercise during chemotherapy infusion may be safe and could potentially combat adverse side effects that patients receive during treatment, said the results of a recent study that is slated to be presented at the 2010 American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 7.
 
Web Exclusives

Feature: U.S. needs national strategy to curb imaging overutilization

Medical imaging overutilization--a growing concern in the U.S.--exposes patients to unnecessary radiation, while also adding to rising healthcare costs, according to a study published online Aug. 24 in Radiology. In an interview, William R. Hendee, PhD, lead author, reviewed various methods by which medical imaging could be curtailed.

Radiology: Prelim study shows CE breast CT outperforms CT, mammo

Dedicated contrast-enhanced (CE) breast CT delivered significantly improved conspicuity of malignant breast lesions, including ductal carcinoma in situ (DCIS), compared with unenhanced breast CT and mammography, according to a study published in the September issue of Radiology.

Radiology: Rad role may evolve as image-guided biopsies trend up

CT, ultrasound and MRI have helped shift biopsy techniques away from more invasive approaches toward image-guided percutaneous techniques, according to a study published in the September issue of Radiology. The trend toward less-invasive approaches translates into enhanced safety and efficiency and could lead to more interaction between patients and radiologists.

CMS Webinar: Incentive payments to offset EHR adoption, not reimburse

The Centers for Medicare & Medicaid Services’ (CMS) EHR incentive payments are not considered reimbursement for money expended on EHR technology, but are intended to offset the cost associated with adoption and ongoing meaningful use, according to CMS during an Aug. 12 webinar.

CMS webinar: Eligible professionals can expect EHR incentives in 2011

Funding incentives for EHR use is the main goal of the Centers for Medicare & Medicaid Services' (CMS) meaningful use initiative, and there are incentive programs for both hospitals and eligible professionals, according to Elizabeth Holland, health insurance specialist at the Department of Health and Human Services, who spoke during a CMS-sponsored webinar Aug. 8.

Webinar: Stage 1 of meaningful use is for quality reporting acclimation

Stage 1 requirements for meaningful use incentives aim to strike a balance between the overall goal of EHR use and widespread adoption, while avoiding added work, said Jonathan Teich, MD, PhD, chief medical informatics officer at Elsevier Health Services, during a HIMSS webinar titled “Meaningful Use: Safety and Quality of Care.”

PORTALS

Advanced Visualization

Molecular Imaging

Integration Tools & Interoperability

More Portal Topics